Drug · DIN 02443066
OFEV
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 29, 2015; first marketed June 29, 2015.
- Drug Identification Number (DIN)
- 02443066
- Company (DIN owner)
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Nintedanib L01EX09
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NINTEDANIB (NINTEDANIB ESILATE) | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 25, 2015: NOC 17030New Drug Submission (NDS)
Other DINs named OFEV
- DIN 02443074 · Marketed